Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
TAIPEI, Aug. 24, 2026 /PRNewswire/ — Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or…
August 24, 2026
Inspira Enterprise Expands into Australia to Accelerate AI-Driven Cybersecurity and Digital Resilience Across Enterprises
SYDNEY, Aug. 24, 2026 /PRNewswire/ — Inspira Enterprise, a global leader in…
August 24, 2026
Amart Furniture to Overhaul Forecasting and Replenishment with RELEX
Australia’s leading furniture retailer replaces legacy planning tools with AI-driven forecasting and…
August 24, 2026
Additional Information on the Ehrmann Family Increasing Its Equity Stake in Artprice by Artmarket as Part of Artprice's "AI-First" Transformation
PARIS, Aug. 24, 2026 /PRNewswire/ — As announced in Artmarket.com’s Q2 2026 press…